Education
About Us
Working with TipRanks
Follow Us
Kinnari Patel Insider Profile
18 Followers
Kinnari Patel, President, Head of R&D and COO at Rocket Pharmaceuticals, holds 554.71K shares in Rocket Pharmaceuticals (Ticker: RCKT). Most recently, Kinnari Patel Sold $6,078 shares of Rocket Pharmaceuticals on Feb 25, 2025 for an estimated value of 64.31K.
Kinnari Patel Rocket Pharmaceuticals (RCKT)President, Head of R&D and COO
Rocket Pharmaceuticals (RCKT)
President, Head of R&D and COO
Ranked #2,484 out of 100,516 Corporate Insiders
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+72.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
President, Head of R&D and COO
Roles that Kinnari Patel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 19, 2020 - Mar 19, 2021
Return:+323.80%
The most profitable trade made by Kinnari Patel
Kinnari Patel's Trading History
List of latest transactions for each holding click on a transaction to see Kinnari Patel's performance on stock
You May Also Like
Kinnari Patel insider profile FAQ
What is the percentage of profitable transactions made by Kinnari Patel?
The percentage of profitable transactions made by Kinnari Patel is 71%.
What is the average return per transaction made by Kinnari Patel?
The average return per transaction made by Kinnari Patel is 72.00%.
What stocks does Kinnari Patel hold?
Kinnari Patel holds: RCKT stocks.
What was Kinnari Patel’s latest transaction?
Kinnari Patel latest transaction was an Informative Sell of $64.31K.
What was Kinnari Patel's most profitable transaction?
Kinnari Patel’s most profitable transaction was an Informative Buy of RCKT stock on March 19, 2020. The return on the trade was 323.80%.
What is Kinnari Patel's role in Rocket Pharmaceuticals?
Kinnari Patel's role in Rocket Pharmaceuticals is President, Head of R&D and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.